carbidopa has been researched along with metoclopramide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fozard, JR; Palfreyman, MG | 1 |
| Barbieri, S; Bevilacqua, M; Lanfredini, M; Micossi, P; Nitti, F; Norbiato, G; Raggi, U | 1 |
| Rampton, DS | 1 |
| Marsden, CD; Parkes, JD; Tarsy, D | 1 |
| Shi, YF; Xia, P | 1 |
| Huang, BY; Huang, CC; Huang, HS; Leu, ML | 1 |
| Vertosick, FT | 1 |
| Bitton, V; Melamed, E | 1 |
| Anile, C; Barbarino, A; De Marinis, L; Maira, G; Menini, E; Merlini, G | 1 |
| Frohman, LA; Gonzalez-Villapando, C; Szabo, M | 1 |
1 review(s) available for carbidopa and metoclopramide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for carbidopa and metoclopramide
| Article | Year |
|---|---|
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Parkinson Disease, Secondary; Pimozide; Placebos; Promethazine | 1975 |
11 other study(ies) available for carbidopa and metoclopramide
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Metoclopramide antagonism of 5-hydroxytryptophan-induced "wet-dog" shake behaviour in the rat.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Brain Chemistry; Carbidopa; Haloperidol; Male; Methysergide; Metoclopramide; Quipazine; Rats; Serotonin; Time Factors | 1979 |
Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: possible therapeutic approach with levodopa and carbidopa.
Topics: Adult; Aldosterone; Body Weight; Carbidopa; Edema; Female; Humans; Hydrazines; Levodopa; Metoclopramide; Renin; Sodium | 1979 |
Hypertensive crisis in a patient given sinemet, metoclopramide, and amitriptyline.
Topics: Acute Disease; Amitriptyline; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Hypertension; Levodopa; Metoclopramide; Middle Aged; Parkinson Disease | 1977 |
Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
Topics: Adult; Carbidopa; Female; Humans; Levodopa; Luteinizing Hormone; Metoclopramide; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin | 1989 |
Abnormalities in the regulation of prolactin in patients on maintenance hemodialysis.
Topics: Adult; Carbidopa; Female; Humans; Kidney Failure, Chronic; Levodopa; Male; Metoclopramide; Middle Aged; Prolactin; Renal Dialysis; Thyrotropin-Releasing Hormone | 1985 |
Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma.
Topics: Autoantibodies; Carbidopa; Dopamine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Metoclopramide; Monoiodotyrosine; Neural Inhibition; Nomifensine; Pituitary Neoplasms; Prolactin; Radioligand Assay; Receptors, Dopamine | 1985 |
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
Topics: Aged; Antipsychotic Agents; Carbidopa; Corpus Striatum; Depressive Disorder; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Metoclopramide; Parkinson Disease, Secondary; Receptors, Dopamine | 1984 |
Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Dopamine; Female; Follow-Up Studies; Humans; Levodopa; Metoclopramide; Pituitary Neoplasms; Prolactin; Sphenoid Bone; Thyrotropin-Releasing Hormone | 1982 |
Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Animals; Carbidopa; Cimetidine; Female; Guanidines; Humans; Levodopa; Male; Metoclopramide; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Rats; Sex Factors | 1980 |